More Information
Summary:Novel conjugates and immimogens derived from lenalidomide and antibodies generated by these immimogens are useful in immunoassays for the quantification and monitoring of thalidomide and lenalidomide in biological fluids.
Bibliography:Application Number: CN2011813575